Dogwood Therapeutics, Inc. (DWTX) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Halneuron Phase 2b Patients Enrolled to Date | 164.00 | FY2026-Q1 |
| Halneuron Phase 2b Patients Recruited | 145.00 | FY2026-Q1 |
Back to DWTX overview · DWTX earnings · DWTX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.